During the American Society of Clinical Oncology (ASCO) conference, an early trial data was presented showing a drug with promising effects in cancer treatments. The new cancer drug was developed through the use artificial intelligence.
Following the earlier discussions on the role of precision medicine in cancer treatment, scientists have developed a potential cancer cure by incorporating the advancement of technology and the sophistication of artificial intelligence in the field of medicine. In fact, Berg, an American biotechnology firm, created a scientific and technological approach of measuring the cells' biochemistry and feed it into a supercomputer.
Artificial Intelligence-Developed Cancer Drug To Outsmart Cancer?
Based on the recently presented data at the biggest cancer conference in the world held in Chicago over the weekend, scientists have a discovered a way to combine the advances in artificial intelligence with medicine, creating the drug named BPM31510. According to BBC News, this artificial intelligence-developed drug aimed to reverse the so-called "Warburg Effect" in cancer.
What Is The 'Warburg Effect'?
The "Warburg Effect" is described as the phenomenon where oncogenic or malignant cells switch their energy supply. It is an observation where most cancer cells depend on aerobic glycolysis, Science Magazine notes.
Supercomputing: The Future Of Cancer
Even though the artificial intelligence-developed cancer drug was still in the days of development, one of Berg founders, Dr. Niven Narain said supercomputing could be the future of cancer. In fact, the trial showed indications that the drug could eradicate malignant tumors.
"I think we're at a very explosive stage, this fusion of biology with technology in helping us understand the basis of this disease more fundamentally," Narain said. "It's going to allow us to make better decisions on how we develop drugs, to whom we give these drugs to so that we're able to increase the survival outcome."
IBM Watson Speeds Up Cancer Research
Speaking of combining artificial intelligence and cancer treatments, IBM Watson is reportedly leading the way in dealing with cancer through artificial intelligent systems. As a matter of fact, the Medical College of Wisconsin and Froedtert Hospital specialists will reportedly use IBM Watson to rapidly match the medical data and charts of cancer patients with clinical trials, The Memo reports.
Meanwhile, an artificial intelligence analysis tool is also helping in the development of a device that can risk in esophageal cancer. University College London's Dr. David G. Graham and his team used salivary transcriptomic data to develop an accurate and non-invasive risk prediction tool to assess esophageal cancer risk, Healio learns.
Do you believe artificial intelligence could outsmart cancer? Share your thoughts below and follow Parent Herald for more news and updates.
